4
Changes in Ownership
Immunovant, Inc. Filed Acc 0001764013-26-000058
Director sold 2,502 shares at $27.17 ($67,979)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Susman Robert Graham Director | 2026-05-01 | Sale 10b5-1 | −2,502 | $27.17 | $67,979 | 36,394 | D |
| Open-market sales · 2,502 sh · avg $27.17 · $67,979 | |||||||
Loading xslF345X06/wk-form4_1777675214.xml…